Neuro Flashcards
imaging used in strokes
non contrast CT, carotid dopplers
scoring systems used in stroke
NIHSS
ROSIER - both used acutely to assess severity and guide tx
On non contrast CT, difference in appearance of ischaemic vs haemorrhage
ischaemia - patch of darker grey
haemorrhage - bright white
Mx haemorrhagic stroke (SAH)
nimodipine - 60mg every 4h for 21d
1st - coiling
2nd - surgical clipping - need craniotomy
Mx ischaemic stroke
CT- exclude haemorrhage
Aspirin 300mg OD/PR 2 weeks.
No AF - clopidogrel 75mg OD life + statin
AF - apixaban + statin
<4.5h - thrombolysis (alteplase)
<4.5h and occluded proximal anterior circulation - thrombolysis and thrombectomy
<6h - thrombectomy
Parkinsons core symptoms
Bradykinesia
Hypertonia
Tremor
(Parkinson plus syndromes)
Multiple Systems Atrophy (MSA) / Shy-Drager Syndrome
S+S
Autonomic dysfunction (postural hypotension, bladder dysfunction)
Cerebellar ataxia
Rigidity > tremor
(Parkinson plus syndromes)
Progressive Supranuclear Palsy (PSP)
S+S
Vertical gaze palsy
Postural instability – falls
Speech disturbance, dementia
(Parkinson plus syndromes)
Corticobasilar Degeneration (CBD)
S+S
Unilateral parkinsonism
Aphasia
Astereognosis (cortical sensory loss) – alien limb phenomenon
(Parkinson plus syndromes)
Dementia with Lewy Bodies (DLB)
S+S
Visual hallucinations
Fluctuating cognition
Dementia – parkinsonism
Difference between Parkinsonism and Parkinson’s disease
DPR - distribution, progression, response
Parkinsonism is a general term that refers to
a group of neuro disorders that cause movement problems similar Parkinson’s disease e.g. tremors, slow movement and stiffness
Distribution - symmetrical
Progression - rapid
Response - poor response to levodopa
Parkinson’s disease is a neurodegenerative brain disorder that progresses slowly
Distribution - asymmetrical
Progression - slower
Response - good response to levodopa
PD Mx
MDT, physio, depression screen
1st
- levodopa
- SINEMET/ co-careldopa = Levodopa + Carbidopa . (Combined with dopa decarboxylase inhibiters)
- MADOPAR = levodopa + benserazide
- MAO-B inhibitors (i.e. selegiline)
- DA agonists (i.e. pramipexole, ropinirole)
2nd adjuncts
- COMT inhibitors e.g. entacapone (peripheral) tolcapone (central and peripheral)
- give with Levodopa to improve compliance but may increase SE
- Amantadine (PO; nicotinic antagonist, DA agonist, non-competitive NMDA antagonist)
- Apomorphine (SC; DA agonist)
- Deep brain stimulation (of subthalamic nucleus)
PD ix
CT MRI - rule out vascular
DaTScan = Dopamine Transporter scan - Can exclude other causes of tremor
Causes of Parkinsonism
drug induced
e.g. antipsychotics, some CCB, cocaine, amphetamines
Other neurodegenerative disorders e.g.multiple system atrophy, Lewy body dementia and progressive supranuclear palsy
Vascular Parkinsonism
Depression - Severe psychomotor retardation can give a parkinsonian appearance, with slow movements and loss of facial expression.
Tumour
Repeated head trauma
What medications to avoid in PD
metoclopramide, haloperidol
dopamine antagonists
Side effects of levodopa
DOPAMINE
Dyskinesia On/off phenomena Psychosis Arterial BP down Mouth dryness Insomnia N&V Excessive daytime sleepiness
What does the Dopa decarboxylase inhibitor help do with levodopa?
Indications?
Prevents levodopa being broken down peripherally, but doesn’t cross the BBB allowing levodopa to be broken down releasing dopamine in the brain.
Predominant motor symptoms, less side effects
Criteria for epilepsy
2 or more epileptic seizures or
1 seizure with epileptogenic markers (EEG or brain malformation)
you do not treat the first episode of seizure unless
abnormal brain architecture (i.e. MRI) or EEG findings
S+S/ stages of tonic clonic seizure
1st - behavioural arrest (i.e. stop writing, stop talking)
2nd - head and eyes turn to one side (it looks painful) – the side they turn is the opposite side to the lesion
3rd - Stiffening
4th - Shaking
What increases chances of seizure
[STRESS]
– ETOH, insomnia,
medications, recreational drugs, trauma, infection, etc.
Epilepsy Ix
A-E - including glucose, consider pabrinex
- ECG - cardiac causes
- MRI - structural causes
- prolactin - distinguishes dissociative seizure from true CNS seizure (raised in central seizures)
Epilepsy Mx
Tonic clonic (during seizure)
Tonic-clonic seizure:
- 1 = Buccal midazolam, PR diazepam / IV lorazepam if IV access
- 2 = IV lorazepam
- 3 = IV phenytoin (phenobarbital if already on regular phenytoin)
- Rapid sequence induction of anaesthesia using thiopental sodium
When to admit a patient with a seizure
- Poor initial response
- First seizure
- Status epilepticus
- high risk of recurrence (hx of recurrent)
Epilepsy Mx
Focal seizure (during seizure)
Focal seizure:
• Conservative measures
• Admission if first seizure or lasts longer than 5 minutes
• Review patients once a year
Definition of status epilepticus
STATUS EPILEPTICUS
- ≥5 minutes OR >3 seizures in an hour (no recovery in between)
LT Mx of tonic clonic seizure
1st line = valproate
2nd = lamotrigine
LT Mx of absence seizure
1st line = valproate, ethosuximide
2nd = lamotrigine
LT Mx of tonic, atonic or myoclonic seizure
1st line = valproate
2nd = levetiracetam
LT Mx of focal seizure
1st line = lamotrigine
2nd = CBZ
SE carbamazepine
Hyponatraemia
Rash
SE Valproate
VALPROATE
V = Vomiting, nausea A = Anorexia L = Liver toxicity P = Pancreatitis R = Retain weight O = Oedema A = Alopecia T = Teratogen, tremors E = Enzyme inhibitor
SE levetiracetam
mood changes
SE Lamotrigine
SJS
Dizzy
SE phenytoin
Enzyme inducer
gum hypertrophy
Which part of brain is affected first in Alzheimers
hippocampus
3 theories for AD
Amyloid - beta amyloid protein forms toxic aggregates
Tau - tau tangles cause damage to neurones
Inflammation - microbial cells increased phagocytosis and decrease levels of neuroprotective proteins
RF for AD
Biological:
- Age
- Genetics (92% sporadic though) - Presenilin 1 and 2, Downs, APEN, APP, ApoE
- Head injury
- Vascular RF e.g. HTN
Psychosocial
- Low IQ
- Poor educational level
S+S are due to which 4 elements of pathophysiology
- Atrophy (neurone loss)
- Plaque formation
- Neurofibrillaty tangle formation
- Cholinergic loss§
S+S presentation of AD
4As
Amnesia
- recent memories first, disorientation
Aphasia
- difficulty finding correct words, speech muddled
Agnosia
- visual e.g prosopagnosia
Apraxia
- dressing, skilled tasks
BPSD = mood change, abnormal behaviour, hallucination/ delusion
Psychiatric presentations - delusions, depression, GAD
Behavioural disturbances - aggression, wandering, sexual disinhibition, explosive temper
Dementia Ix
- GPCOG
- AMTS (<8/10)
- MMSE (20-24 = mild dementia, 13-20 = moderate dementia, and <12 = severe dementia.
Bloods
- LFT, TFT, U+E, HbA1c, B12 and folate
MRI CT
Prognostic factors in AD
Good - female
Bad - male, depression, behavioural problems, severe focal cognitive defect
AD Mx
Biological - start low, go slow
1st = anticholinesterases (mild-moderate)
- Donepezil (reversible)
- Galantamine (reversible)
- Rivastigmine (pseudo-reversible)
2nd = NMDA glutamate partial receptor agonist (moderate, 1st line in severe)
- Memantine
Psych
1st = structural group cognitive stimulation sessions (mild-mod)
- exclude GAD/ depression
- multisensory therapy
- group reminiscence therapy
- validation therapy
Social
- explain diagnosis
- optimising health e.g. hearing, vision
- identify future wishes e.g. AD, LPA
- carers
- social support
- FU every 6m with yourself and a dingle care managed
- DVLA, insurers
General
- wear ID
- dossed boxes
- change gas to electricity
Anticholinesterases - must check
ECG
Anticholinesterases SE
GI - NV, diarrhoea, anorexia
fatigue, dizziness, headache
Anticholinesterases absolute CI
anticholinergics (block ACh from binding)
BB
NSAIDs
muscle relaxants
Migraine S+S, Mx
unilateral, throbbing, severe, 4-72h
Migraine Mx
acute, prophylaxis
Acute
- oral triptan + NSAID/ paracetamol
Prophylaxis
- topiramate/ propanolol (only if >2 attacks a month)
Cluster headache S+S,
Intense pain around eye, watering; last 15m-2hrs
Cluster headache Mx
acute, prophylaxis
Acute: 100% O2, SC triptan
Prophylaxis: verapamil
Temporal arteritis S+S
Headache, jaw claudication, tender scalp
Temporal arteritis Mx
Oral prednisolone
Medication-overuse headache S+S and Mx
≥15 days / month, worsened with medication
stop meds
Define MS
an autoimmune demyelinating disorder of the CNS characterised by multiple plaques of separate in time and space
Classification of MS
Relapsing remitting
Primary progressive
Secondary progressive
Progressive relapsing
S+S of MS
TEAM
Tingling
Eye / optic neuritis
Ataxia (and other cerebellar signs DANISH)
Motor (spastic paraparesis)
INO
What is Lhermitte’s sign
Neck flexion –> electric shocks in trunk or limb
What is Uhthoff’s sign
temporary worsening of MS symptoms with increased temperature – i.e. a hot bath, exercise
What is INO
lesion in the medial longitudinal fasciculus (MLF) connecting CN6 to CN3 (and CN 4) which has S/S of weak adduction of ipsilateral eye and nystagmus of the contralateral eye
Criteria for MS
McDonald criteria - demonstrating lestions disseminated in time and space
MS Ix
o Contrast MRI (gadolinium-enhanced, T2-weighted)
o LP (IgG oligoclonal bands)
o Blood antibodies:
- Anti-MBP (myelin basic protein)
- NMO-IgG (neuromyelitis optica) Devic’s syndrome (S/S: MS + transverse myelitis + optic atrophy)
o Evoked potentials
MS differentials
stroke tumour CNS sarcoidosis SLE Devic's syndrome
MS Management
ACute
chronic
Sx Mx
Acute
- methyprednisolone 1g IV/PO OD for 3d
Chronic
- DMARDs - IFN beta
- Biologics - natalizumab
MS symptom management
Drug for
Fatigue
modafinil
MS symptom management
Drug for
Depression
SSRI
MS symptom management
Drug for pain
amitryptiline, gabapentin
MS symptom management
Drug for spasticity
baclofen + gabapentin
MS symptom management
Drug for urgency/ frequency
oxybutynin, tolterodine
MS symptom management
Drug for
tremor
clonazepam
MS good and bad prognostic factors
Good
- female
- <25yo
- sensory signs at onset
- long interval in relapses
- few MRI lesions
Bad
- male
- older
- motor signs at onset
- short interval in relapses
- many MRI lesions
- axonal loss
Myasthenia gravis definition
Autoimmue disorder characterised by insufficient functioning NACh receptors
Myasthenia gravis antibody
Anti-ACh-R in 85-90% cases
Anti muscle specific receptor TK AB 40%
Myasthenia gravis associations
15% thymoma
50-70% thyme hyperplasia
AI disease e.g. RA, SLE, AI thyroid
MG S+S
Muscle fatiguability
Extraocular (diplopia, ptosis), bulbar, face and neck muscles affected
Proximal myopathy - face neck, limb girdle
Dysphagia
Reflexes normal
MG Exacerbating drugs
Penicillamine BB Quinidine, procainamide Lithium Phenytoin Abx - gentamicin, macrolides, quinolones, tetracyclines
Causes of myasthenia crisis
emotion, exercise, hypokalaemia, drugs e.g. opiates, BB, abx